Skip to content
20-F

Annual Report (Foreign)

NIGHTSTAR THERAPEUTICS PLC

0001564590-18-007555

← back to feed
Filed
Apr 3, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Dec 31, 2017 28.9M sh
Cash And Equivalents FY 2017 · Dec 31, 2016 $10.12M
Cash And Equivalents FY 2017 · Dec 31, 2015 $10.68M
Cash And Equivalents FY 2017 · Dec 31, 2014 $7.16M
Current Liabilities FY 2017 · Dec 31, 2016 $5.55M
Total Liabilities FY 2017 · Dec 31, 2016 $5.55M
Current Assets FY 2017 · Dec 31, 2016 $14.23M
Total Assets FY 2017 · Dec 31, 2016 $14.6M
Capex FY 2017 · Dec 31, 2015 $289K
Sga Expense FY 2017 · Dec 31, 2015 $2.15M
Rd Expense FY 2017 · Dec 31, 2015 $7.18M
Net Income FY 2017 · Dec 31, 2015 −$13.65M
Stockholders Equity FY 2017 · Dec 31, 2014 $3M